NEUROENDOCRINE TUMORS
Clinical trials for NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug entinostat studied for rare abdominal cancer, trial halted early
Disease control TerminatedThis study tested a drug called entinostat in people with advanced abdominal neuroendocrine tumors that had come back or stopped responding to other treatments. Only 5 people enrolled before the trial was stopped early. The goal was to see if the drug could shrink tumors or slow …
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Promising cancer drug trial halted after just one patient
Disease control TerminatedThis study aimed to see if giving Lutathera (a radioactive drug) after surgery to remove liver metastases from neuroendocrine tumors could help keep the cancer from coming back. It planned to compare Lutathera plus best supportive care against best supportive care alone in about …
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC